TY - JOUR
T1 - Potential benefits of phytochemicals for abdominal aortic aneurysm
AU - Hosseini, Azar
AU - Penson, Peter E.
AU - Cicero, Arrigo F.G.
AU - Golledge, Jonathan
AU - Al-Rasadi, Khalid
AU - Jamialahmadi, Tannaz
AU - Sahebkar, Amirhossein
N1 - Funding Information:
Peter E. Penson wrote the draft of the paper. Arrigo FG Cicero, Khalid Al-Rasadi, Jonathan Golledge and Tannaz Jamialahmadi critically revised the paper. All the authors have read and approved the final version of the paper. Jonathan Golledge holds a Practitioner Fellowship from the National Health and Medical Research Council (1117061) and a Senior Clinical Research Fellowship from the Queensland Government, Australia.
Publisher Copyright:
© 2021 Bentham Science Publishers.
PY - 2021/12
Y1 - 2021/12
N2 - Background: Abdominal aortic aneurysms (AAAs) are a leading cause of death in older adults due to aortic rupture. There are currently no effective medical therapies for AAA, with surgery being the only acceptable treatment. There is frequently an extended period between AAA diagnosis and treatment by corrective surgery, during which an effective drug therapy could prevent or delay the need for AAA repair. Objec-tive: This review aimed to critically summarize prior research investigating the potential benefits of phytochemicals in preventing or treating AAA. Methods: In vitro, in vivo, and human studies examining the effect of phytochemicals in AAA models and patients were critically summarised. Results: Some preliminary data support the further investigation of curcumin, radix astra-gali, grape seed polyphenols, resveratrol, Ginkgo biloba extract (EGb 761), Ginsenoide Rb1, Dan Hong, Epigallocatechin-3-gallate, Baicalein, Fucoidan, Quercetin, and Sal-vianolic acid as potential treatments for AAA. Conclusion: Experimental in vivo and in vitro studies suggest the potential benefits of a number of medicinal herbs and phytochemicals in preventing or reducing the progression of AAA. In order to assess whether these findings can be translated into proven treat-ments, adequately designed double-blind randomized clinical trials will be required.
AB - Background: Abdominal aortic aneurysms (AAAs) are a leading cause of death in older adults due to aortic rupture. There are currently no effective medical therapies for AAA, with surgery being the only acceptable treatment. There is frequently an extended period between AAA diagnosis and treatment by corrective surgery, during which an effective drug therapy could prevent or delay the need for AAA repair. Objec-tive: This review aimed to critically summarize prior research investigating the potential benefits of phytochemicals in preventing or treating AAA. Methods: In vitro, in vivo, and human studies examining the effect of phytochemicals in AAA models and patients were critically summarised. Results: Some preliminary data support the further investigation of curcumin, radix astra-gali, grape seed polyphenols, resveratrol, Ginkgo biloba extract (EGb 761), Ginsenoide Rb1, Dan Hong, Epigallocatechin-3-gallate, Baicalein, Fucoidan, Quercetin, and Sal-vianolic acid as potential treatments for AAA. Conclusion: Experimental in vivo and in vitro studies suggest the potential benefits of a number of medicinal herbs and phytochemicals in preventing or reducing the progression of AAA. In order to assess whether these findings can be translated into proven treat-ments, adequately designed double-blind randomized clinical trials will be required.
KW - Abdominal aortic aneurysm
KW - Inflammation
KW - Oxidative stress
KW - Phytochemi-cals
KW - Phytotherapy
KW - Plant medicine
UR - http://www.scopus.com/inward/record.url?scp=85121700397&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85121700397&partnerID=8YFLogxK
U2 - 10.2174/0929867328666210614113116
DO - 10.2174/0929867328666210614113116
M3 - Review article
C2 - 34126879
AN - SCOPUS:85121700397
SN - 0929-8673
VL - 28
SP - 8595
EP - 8607
JO - Current Medicinal Chemistry
JF - Current Medicinal Chemistry
IS - 41
ER -